Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

I’m Sometimes Grateful for My Chemo Brain and Multiple Jobs During Cancer

December 6th 2022

I’ve realized that my forgetfulness and business of working multiple jobs through cancer might have actually helped my mental health.

Educated Patient® Metastatic Breast Cancer Summit Addressing Unmet Needs Panel: November 12, 2022

November 29th 2022

Watch Dr. Leif Ellisen, Dr. Dejan Juric, Dr. Beverly Moy and Natasha Mmeje answer questions about unmet needs during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Addressing Breast Cancer Disparity Presentation: November 12, 2022

November 28th 2022

Watch Dr. Beverly Moy, from Massachusetts General Hospital, discuss addressing breast cancer disparity during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Addressing Therapeutic Resistance Presentation: November 12, 2022

November 27th 2022

Watch Dr. Dejan Juric, from Massachusetts General Hospital, discuss therapeutic resistance during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit HER2 and Triple-Negative Disease Panel: November 12, 2022

November 26th 2022

Watch Dr. Aditya Bardia, Dr. Arielle J. Medford and Dr. Neelima Vidula answer questions about HER2 and triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Management of Triple Negative Disease Presentation: November 12, 2022

November 25th 2022

Watch Dr. Neelima Vidula, from Massachusetts General Hospital, discuss the management of triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

November 24th 2022

Watch Dr. Arielle J. Medford, from Dana-Farber Cancer Institute, discuss the management of HER2-positive disease during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit HR-Positive Disease Panel: November 12, 2022

November 23rd 2022

Watch Dr. Aditya Bardia, Dr. Seth A. Wander and Dr. Laura M. Spring answer questions about HR-positive disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Overview of Management of Hormone Receptor-positive Breast Cancer: Third Line and Beyond Presentation: November 12, 2022

November 22nd 2022

Watch Dr. Laura M. Spring, from Massachusetts General Hospital in Boston, discuss treatment in third line and beyond for hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Overview of Management of Hormone Receptor-positive Breast Cancer Presentation: November 12, 2022

November 21st 2022

Watch Dr. Seth A. Wander, from Massachusetts General Hospital in Boston, discuss the first- and second-line treatment of hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

Educating Patients About Cancer Disparities Can Empower Them in Screening and Treatment Decisions

November 16th 2022

When patients are aware of cancer disparities, it can empower them to be proactive about their care to close the prognostic gap between races.

This Breast Cancer Awareness Slogan Really Stuck Out, and Not in a Good Way

November 4th 2022

I had a wonderful time at a recent breast cancer walk, until I got home and found a bracelet with a raunchy saying on it in my survivor’s gift bag.

Is it Possible to Have a Broad-Based Cancer Team in a Rural Area?

November 4th 2022

With a little luck and a lot of coordination, I managed to create an excellent and comprehensive cancer care team in the least populated state in the country.

My Team of Local and Research-Based Oncologists Is the Best of Both Worlds

November 2nd 2022

Since I have stage 4 breast cancer, I wanted an oncologist affiliated with a research institution. However, I hated the prospect of frequent long drives for care. Luckily, I got the best of both worlds.

Every Day Financial Toxicity: Even With Good Insurance, the Smaller Costs of Cancer Care Add Up

November 1st 2022

When people say. “It’s just $35 to see a specialist,” they miss the entire issue of cancer-related financial toxicity.

FDA to Speed Up Review of Trodelvy for HR-Positive, HER2-Negative Metastatic Breast Cancer

October 12th 2022

The Food and Drug Administration granted a priority review to Trodelvy for previously treated locally advanced or metastatic HR-positive, HER2-negative breast cancer.

A Month of Pink Is Not Enough to Prevent Breast Cancer Deaths

October 11th 2022

I wish “Pinktober” was more about saving the people who will die from breast cancer and less about pink ribbons and sexualizing the disease.

Standup Comedian and Self-Proclaimed 'Love Goddess' Judy Tenuta Dies From Cancer, New England Patriots Host a ‘Day of Pampering’ for Cancer Survivors and More

October 7th 2022

From the death of standup comedian and "Love Goddess" Judy Tenuta to professional sports hall-of-famers discussing their cancer, here’s what’s happening in the cancer space this week.

Coming Full Circle: How a Patient Worked With a Breast Cancer Drug Years Before Reclassification of Her Disease Led to the Same Treatment

October 6th 2022

A patient with metastatic breast cancer shares how she learned that her disease was recently reclassified as HER-2 low, and what it was like to first learn about the FDA-approved drug years before she would be prescribed the treatment.

From Cancer Progression to COVID-19, I Searched for Light During My Darkest Days

September 28th 2022

On the same day that I learned of my cancer progression, I also found out I had COVID-19. Here’s how I handled that dark period of life.

Extra Years Together Meant We Aged Out of a Free Vacation for Families Affected by Cancer

September 16th 2022

Extra years with my family meant missing out on a free trip granted to patients with cancer who have children under the age of 18 — and I’m OK with that.

Why I Advocate for Aesthetic Flat Closure After Breast Cancer Surgery

September 13th 2022

As “Pinktober” approaches, I’m spreading the message that breasts are not needed to live a full life after breast cancer surgery.

Trodelvy May Fulfill Unmet Need for Subset of Patients With Metastatic Breast Cancer

September 10th 2022

Compared to physician’s choice of treatment, Trodelvy improved survival and quality of life in pretreated patients with HR positive/HER2 negative metastatic breast cancer.

5 Ways I Turn Anger Into Cancer Advocacy and Get Busy Livin’

September 7th 2022

I’ve channeled my cancer-related anger into advocacy, and made a “living list” of things I want to accomplish.

Trodelvy Lengthens Time to Disease Progression in Metastatic Breast Cancer

September 7th 2022

Trodelvy bested chemotherapy for progression-free survival in patients with HR-positive, HER2-negative metastatic breast cancer.

I’m Not a ‘Cancer Warrior,’ But I Am a ‘Joy Warrior’

August 30th 2022

I’m giving cancer’s “battle language” an update and focusing my survivorship plan on emotional wellbeing and honesty.

Unraveling the Layers of Metastatic Breast Cancer

August 22nd 2022

The death of “Grease” star Olivia Newton-John from metastatic breast cancer has triggered discussions about the specifics of the disease. Here, CURE® details what metastatic breast cancer is.

Patient With Metastatic Breast Cancer Recalls Witness of Data Leading to Enhertu Approval in HER2-Low Disease

August 17th 2022

A patient with metastatic breast cancer recalls the emotional experience of being among the thousands of attendees who gave a standing ovation in an auditorium in Chicago when the results of the phase 3 DESTINY-Breast04 trial — which recently led to the FDA approval of Enhertu in HER2-low disease — were presented at the 2022 ASCO Annual Meeting.

FDA Grants Enhertu a Priority Review for Metastatic HER2-Low Breast Cancer

July 25th 2022

If approved, Enhertu may “redefine how we classify and treat metastatic breast cancer,” according to a representative from the drug’s manufacturer.

Patient Advocacy at ASCO 2022

July 22nd 2022

This year, I returned to the American Society of Clinical Oncology meeting, where I heard about the latest advancements in cancer care, as well as met with fellow patients and advocates.

NEXT PAGE
PREVIOUS PAGE